top of page

Thought Leadership Speaker Series: Dr Carl Runde

We are back, live and in-person, to relegate 2022 to the annals of history. The next speaker in our Thought Leadership Speaker Series is Dr Carl Runde (Chief Financial Officer at Atmo BioSciences).

Carl Runde is finance professional with a passion for driving inclusive approaches to sustainable growth and stakeholder value creation. He has more than twenty years of international medical device industry experience in corporate financial analysis, valuation modelling, and strategic business planning.


Carl was awarded a Doctoral degree from the University of Sydney Business School and explored the role of management and project team diversity and inclusion on product development and commercial performance

bottom of page